Global Executive | End to End Precision Health Leader | Collaborative Strategist & Innovator | Human Centered Design
Great panel discussion between MassiveBio, Nucleai, and PathAI on commercialization and implementation of AI in precision oncology today at Tri-Con. Collaboration amongst our brightest companies and minds in AI is the better way to move quickly to revolutionizing healthcare. Thanks Ben Glass Arturo LoAIza-Bonilla MD Oscar P. and John Mattison
Awesome to see this Jennifer Quigley
Our CEO and co-founder, Avi Veidman, was featured in a STAT article, emphasizing the importance of spatial AI biomarkers in improving patient enrollment for clinical trials. The piece explores how AI is revolutionizing drug development and propelling precision medicine forward. Dive into the full story for more insights. 📖✨ https://bit.ly/4aIKOPL #spatialbiomarkers #AI #biopharma #clinicaltrials #CDx #biomarkers #precisionmedicine #precisiononcology #spatialbiology
CURIOUS 2024: Workshop »Potentials of Al to Transform Precision Medicine« SAVE THE DATE: Wednesday, July 10, 17:00 – 18:30 in Dome 5 Is Al just a hype or will it transform pathology and diagnostics? Are we about to reinvent cancer care? Where are we currently regarding usage of AI in diagnostics? What obstacles must be overcome? These and other questions are going to be discussed by Dieter Fellner (Fraunhofer IGD) and Horst Hahn (Fraunhofer MEVIS) with the expert panelists Fabien Gaire (Roche Pharma Development Datascience), Katrien Grünberg (University Medical Center in Nijmegen), Ralf Kuhlen (Helios Health), and Stefan Wrobel (Fraunhofer IAIS) in their workshop about how AI solutions in healthcare can be transferred from research into clinical application. This addresses one use case that powerfully demonstrates the potential of AI to improve diagnostics and that is of great importance to oncology and the pharmaceutical industry: tissue analytics and AI-enabled digital pathology informed by Peta-scale datasets. You will find more information here: https://lnkd.in/eFjZ8TnD Future Insight e.V. #CURIOUS2024 #AI #BigData #Diagnostics #Oncology #TissueAnalytics #DigitalPathology #PrecisionMedicine
If you missed the MAP 2024 conference, here's some of our highlights 👇 💉 MAP 2024 nicely summarised recent discoveries in precision medicine, technologies for cancer profiling, and biomarker-driven development of targeted therapeutics. But it omitted advances in proteomics - where there has been notable progress. We would welcome the opportunity to showcase this next year! 🤖 Important topics/challenges discussed in this session included: ethical and privacy concerns; integration with current IT-systems; data availability; what is appropriate clinical validation; and the extent of user guidance/ training required for proper-use. All big challenges as AI rapidly approaches the clinic 🗺️ The programme nicely built up to the ‘RoadMAP to the clinic’ session, which focused on new AI-based developments and their implementation in clinical practice. The main take home was that while there are some great exemplars of AI in the clinic, it’s important to support its success with the necessary infrastructure Congratulations to ESMO - European Society for Medical Oncology for putting on such an inspiring event, full of discussions and guidance on the use of AI for drug development and clinical practice. We look forward to returning next year! Photo credit - MAP2024 #MAP2024 #precisionmedicine #diagnostics #clinicaltrials #clinicaloncology #AI #kinomica
Docviser is at Romanian Healthcare Conference & Expo to talk about digital best practices and AI applied in oncology at the innovation panel. Special thanks to our partner Affidea for inviting us to the panel discussion. Find Iliescu Alexandru to find out more about us and how Docviser can streamline your oncology practice using cutting edge technology and user experience in a secured and compliant environment. #digital #innovation #medical #software #ai #oncology #bestpractices #compliance
Excited to have you speaking at this year's Retinal Imaging Biomarkers & Endpoints meeting, Yasin! If you're interested in learning more about Yasin's full presentation details, you can do so here - https://ter.li/p4jllc #retinalimaging #ophthalmicimaging
I am excited to be speaking at the 2nd Retinal Imaging Biomarkers & Endpoints Summit this June 25-27 in Boston, MA! I will be presenting on Functional Testing in Clinical Trials for Geographic Atrophy. Will you be joining me there? Learn more about the conference here: https://ter.li/p4jllc
Streamline your clinical data operations with MaxisIT Inc.'s AI-Powered Data Management Workbench (DMW). Our case study with a leading Oncology biotech company highlights significant time savings and enhanced efficiency. Swipe through the carousel to see how DMW’s automation is transforming data management, freeing up valuable resources, and significantly enhancing overall clinical trials effectiveness. Explore more here: https://lnkd.in/eUF78Kpi #ClinicalTrials #ClinicalResearch #ClinicalDataManagement #AI #Oncology #Biotech #MaxisIT
Frontier Merchant Capital Group works with small private and listed companies across a wide range of sectors
🚀 Dive into the future of drug discovery! Join us this Wednesday, February 28, for a live discussion on #Xspaces. 🤖🧬 @Rakovina_RKV in collaboration with Follow the Money Investor Group Discover the transformative power of AI in the drug discovery process with insights from industry leaders 👇 Jeffrey Bacha, our Executive Chairman Mads Daugaard, our President & Chief Scientific Officer and Artem Cherkasov, the newest member of our Scientific Advisory Board Don't miss out on this dynamic conversation shaping the future of oncology. See you there! 👩🔬👨💼 #AI #DrugDiscovery #Innovation #biotech
🚀 Dive into the future of drug discovery! Join us this Wednesday, February 28, for a live discussion on #Xspaces. 🤖🧬 @Rakovina_RKV in collaboration with Follow the Money Investor Group Discover the transformative power of AI in the drug discovery process with insights from industry leaders 👇 Jeffrey Bacha, our Executive Chairman Mads Daugaard, our President & Chief Scientific Officer and Artem Cherkasov, the newest member of our Scientific Advisory Board Don't miss out on this dynamic conversation shaping the future of oncology. See you there! 👩🔬👨💼 #AI #DrugDiscovery #Innovation #biotech
New research report from Median Technologies now available! Download now to examine: • The pivotal role of imaging in oncology clinical trials • Strategies for managing image reader variability • The critical use of AI in resolving these challenges ...and more! Download your free report: https://ow.ly/IzT850SeRfY. #MedicalImaging #OncologyResearch #HealthcareInnovation #ImagingTechnology #RadiologyInsights
🚀 Dive into the future of drug discovery! Join us this Wednesday, February 28, for a live discussion on #Xspaces. 🤖🧬 @Rakovina_RKV in collaboration with Follow the Money Investor Group Discover the transformative power of AI in the drug discovery process with insights from industry leaders 👇 Jeffrey Bacha, our Executive Chairman Mads Daugaard, our President & Chief Scientific Officer and Artem Cherkasov, the newest member of our Scientific Advisory Board Don't miss out on this dynamic conversation shaping the future of oncology. See you there! 👩🔬👨💼 #AI #DrugDiscovery #Innovation #biotech
🎗️We've just unveiled an exclusive collaboration with Dr. Artem Cherkasov and have integrated a proprietary Deep Docking AI Platform for DNA-damage response targets into our business model. With this proprietary AI platform, we're revolutionizing the discovery and development of targeted cancer drugs. 🧬💊 Our team can now rapidly evaluate billions of molecular structures, focusing on DNA-damage response-related vulnerabilities prevalent in various cancer types. This innovative approach enables us to expedite the drug discovery process.💡 From preclinical research to human clinical trials and potential partnerships, we're accelerating the journey to groundbreaking therapies. Our commitment to advancing precision medicine and delivering hope to millions of patients remains steadfast. 💪 With the support of Dr. Artem Cherkasov and the Deep Docking AI Platform, Rakovina is poised to make significant strides in the fight against cancer. 🌟 Join us as we embark on this transformative journey! Together, we're reshaping the future of cancer treatment. 🌌 #RakovinaTherapeutics #PrecisionMedicine #AIinHealthcare #CancerResearch 🎉 https://lnkd.in/gxS59_6A
Head Translational Medicine & Diagnostics at Nucleai. Associate Editor of the journal Artificial Intelligence in Precision Oncology. I am a Dad, an Ironman, and support the Kyle Pease foundation.
7moThanks Jennifer!!! I really enjoyed the discussion!!!